… could be promising prophylactic therapeutics for COVID-19. … as a promising prophylactic,
therapeutic candidate for COVID-19. … be a potential prophylactic therapeutic for COVID-19 in the …

… This article outlines the prophylaxis therapeutic potential of supplements vitamins and
micronutrients in COVID-19. By ameliorating the inflammatory and oxidative stress associated with …

… in COVID-19 patients, especially those admitted to intensive care units is challenging in the
rapidly evolving pandemic of novel coronavirus disease 2019 (COVID-19… ) among COVID-19 …

… Whether therapeutic anticoagulation improves outcomes in patients hospitalised … COVID-19
is unknown. We aimed to compare the efficacy and safety of therapeutic versus prophylactic …

… In this randomized, open-label, phase II study, we randomized COVID-19 patients
requiring mechanical ventilation to receive either therapeutic enoxaparin or the standard …

… of a 10-day course of therapeutic-dose bemiparin does not … prophylactic doses. Further
research is needed to evaluate other therapeutic strategies and identify subgroups of COVID-19 …

… covid-19 and with increased D-dimer levels were recruited between 29 May 2020 and 12
April 2021 and were randomly assigned to therapeutic dose heparin (n=228) or prophylactic …

… Recent studies demonstrate the potential of quercetin against COVID-19. This article
highlighted the prophylactic/therapeutic potential of quercetin against COVID-19 in view of its …

… Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19
and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, …

… , prophylaxis, therapy) are guided by the clinical context and the COVID-19 severity. We
provide a practical approach on antithrombotic therapy management for COVID-19 patients from …